Pharmaceuticals

Global Asthma Drugs Market Size and Forecast to 2029: Revenue, Growth, and Trends

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the asthma drugs market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Asthma Drugs Market Size Today And What Will Its Value Be At The End Of 2029?

The asthma drugs market has shown consistent expansion over recent years. It is anticipated to increase from $23.96 billion in 2024 to $24.93 billion by 2025, reflecting a compound annual growth rate (CAGR) of 4.0%. This historical growth can be ascribed to several factors, including environmental factors, increased respiratory disorders, lifestyle changes, and healthcare infrastructure development.

The asthma drugs market size is projected to experience substantial growth in the near future. The market is forecast to expand to $31.38 billion by 2029, achieving a compound annual growth rate (CAGR) of 5.9%. This expected expansion during the forecast period is driven by factors such as increasing air pollution levels, a growing aging population, enhanced healthcare awareness, developments in personalized medicine trends, and biopharmaceutical innovations. Significant trends identified for the upcoming period involve small molecule therapies, home-based asthma care, biomarker-guided therapies, improvements in severe asthma treatments, and collaborations for asthma research.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

Which Key Drivers Are Powering Growth In The Asthma Drugs Market?

A significant occurrence of asthmatic conditions is projected to drive the expansion of the asthma drug market in the future. Asthma is characterized as a chronic ailment leading to inflammation and swelling in the airways, which subsequently constricts the passages responsible for transporting air from the nose and mouth to the lungs. Due to the rising incidence of asthma, there has been a notable increase in the discovery of novel asthma medications aimed at managing asthmatic conditions. For example, data from April 2024, provided by Asthma + Lung UK, an England-based charity aiding individuals with lung conditions, indicated that in 2021, asthma-related deaths in England totaled 1,146. This number subsequently climbed to 1,236 in 2022, highlighting a worrying escalation in fatalities linked to the condition within that year.

Which Segment Categories Are Driving Maximum Growth In The Asthma Drugs Market?

The asthma drugs market covered in this report is segmented –

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive, Curative

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients, COPD Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

What Key Trends Are Driving Growth In The Asthma Drugs Market?

Key players within the asthma drugs market are prioritizing advancements, such as fixed-dose combination (FDC) drugs, to boost the effectiveness of treatment and patient adherence. An FDC drug is defined as a medication containing two or more active ingredients merged into a single dosage form, like a tablet, capsule, or inhaler. For example, in June 2022, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched Indamet, an FDC drug in India, specifically for patients with uncontrolled asthma. This innovative treatment combines Indacaterol, a long-acting beta-agonist, with Mometasone Furoate, an inhaled corticosteroid, and is available in various strengths, including Indacaterol 150 mcg with Mometasone at 80 mcg, 160 mcg, and 320 mcg. Intended for once-daily administration, Indamet is aimed at adults and adolescents aged 12 years and older.

Who Are The Leading Companies Driving The Asthma Drugs Market?

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Which Region Holds The Largest Share In The Asthma Drugs Market Today?

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp

Browse Through More Reports Similar to the Global Asthma Drugs Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795